Redcare Pharmacy NV Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	2,821	2,371	1,799	1,204	1,060	968.06
Revenue Growth (YoY)	26.68%	31.79%	49.35%	13.58%	9.53%	38.09%
Cost of Revenue	2,175	1,825	1,358	872.57	793.53	748.53
Gross Profit	645.38	545.78	440.38	331.79	266.8	219.53
Selling, General & Admin	675.12	581.07	444.49	379.17	299.21	214.04
Other Operating Expenses	-0.35	-0.35	-0.32	-0.15	-0.16	-0.07
Operating Expenses	674.76	580.73	444.18	379.02	299.05	213.97
Operating Income	-29.38	-34.95	-3.79	-47.23	-32.25	5.56
Interest Expense	-19.45	-7.78	-8	-8.5	-8.57	-10.76
Interest & Investment Income	18.33	6.4	4.61	-	-	-
Earnings From Equity Investments	0.62	0.42	0.23	0.34	-0.43	0.05
Currency Exchange Gain (Loss)	0.52	0.52	0.28	1.76	1.49	-0.23
Other Non Operating Income (Expenses)	-8.37	-8.37	-7.02	-6.97	-4.53	-3.72
EBT Excluding Unusual Items	-37.74	-43.76	-13.7	-60.6	-44.28	-9.11
Merger & Restructuring Charges	-	-	-	-0.32	-	-
Gain (Loss) on Sale of Investments	-	-	-	-1.58	-0.16	-0.4
Other Unusual Items	-6.1	-4.08	-0.65	-21.62	-33.45	-6.42
Pretax Income	-43.84	-47.83	-14.35	-84.12	-77.88	-15.93
Income Tax Expense	-7.46	-1.48	-2.74	-6.47	-3.7	0.84
Earnings From Continuing Operations	-36.38	-46.36	-11.61	-77.65	-74.19	-16.77
Minority Interest in Earnings	1.2	0.89	-0.44	-	-	-
Net Income	-35.19	-45.46	-12.04	-77.65	-74.19	-16.77
Net Income to Common	-35.19	-45.46	-12.04	-77.65	-74.19	-16.77
Shares Outstanding (Basic)	-	20	19	18	18	14
Shares Outstanding (Diluted)	-	20	19	18	18	14
Shares Change (YoY)	-	4.24%	6.97%	0.57%	24.37%	10.07%
EPS (Basic)	-	-2.27	-0.63	-4.32	-4.15	-1.17
EPS (Diluted)	-	-2.27	-0.63	-4.32	-4.15	-1.17
Free Cash Flow	-22.53	13.38	55.02	-42.68	-2.18	-20.43
Free Cash Flow Per Share	-	0.67	2.86	-2.37	-0.12	-1.42
Gross Margin	22.88%	23.02%	24.48%	27.55%	25.16%	22.68%
Operating Margin	-1.04%	-1.47%	-0.21%	-3.92%	-3.04%	0.57%
Profit Margin	-1.25%	-1.92%	-0.67%	-6.45%	-7.00%	-1.73%
Free Cash Flow Margin	-0.80%	0.56%	3.06%	-3.54%	-0.21%	-2.11%
EBITDA	-6.49	-12.83	14.47	-34	-21.6	12.8
EBITDA Margin	-0.23%	-0.54%	0.80%	-2.82%	-2.04%	1.32%
D&A For EBITDA	22.89	22.12	18.27	13.23	10.65	7.24
EBIT	-29.38	-34.95	-3.79	-47.23	-32.25	5.56
EBIT Margin	-1.04%	-1.47%	-0.21%	-3.92%	-3.04%	0.57%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.